110 related articles for article (PubMed ID: 15020351)
1. Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance.
Mohren M; Daikeler T; Benz D; Günaydin I; Kanz L; Kötter I
Ann Rheum Dis; 2004 Apr; 63(4):466-7. PubMed ID: 15020351
[No Abstract] [Full Text] [Related]
2. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
[No Abstract] [Full Text] [Related]
3. Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation.
Girnius S; Seldin DC; Quillen K; Dember LM; Segal A; Sanchorawala V
Bone Marrow Transplant; 2011 Jan; 46(1):161-2. PubMed ID: 20383204
[No Abstract] [Full Text] [Related]
4. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG
Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541
[No Abstract] [Full Text] [Related]
5. Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: First Moroccan experience.
Belkhribchia MR; Tazi I; Louhab N; Kissani N; Mahmal L; Pereon Y
Presse Med; 2017 Jan; 46(1):122-125. PubMed ID: 27818064
[No Abstract] [Full Text] [Related]
6. [High dose treatments and preparatory regimens prior to haematopoietic stem cell transplantation].
Tomíška M
Vnitr Lek; 2012; 58(7-8):581-6. PubMed ID: 23067183
[TBL] [Abstract][Full Text] [Related]
7. Refractory CIDP successfully treated with autologous haematopoietic stem cell transplantation in a patient with monoclonal gammopathy of undetermined significance (MGUS) and rheumatoid arthritis.
Lopes C; Costa A; Bergantim R; Silveira F; Nadais G
Neuromuscul Disord; 2022 Jan; 32(1):71-74. PubMed ID: 34920930
[TBL] [Abstract][Full Text] [Related]
8. Occult autologous haematopoietic regeneration without disease relapse following myeloablative allogeneic haematopoietic SCT for lymphomas.
Au WY; Lam KK; Leung AY; Liang RH; Lie AK; Kwong YL
Bone Marrow Transplant; 2010 Aug; 45(8):1377-8. PubMed ID: 20023709
[No Abstract] [Full Text] [Related]
9. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
[TBL] [Abstract][Full Text] [Related]
10. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation.
Woods AC; Mant MJ
Ann Rheum Dis; 2006 May; 65(5):697. PubMed ID: 16611874
[No Abstract] [Full Text] [Related]
13. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Burt RK; Loh Y; Cohen B; Stefoski D; Balabanov R; Katsamakis G; Oyama Y; Russell EJ; Stern J; Muraro P; Rose J; Testori A; Bucha J; Jovanovic B; Milanetti F; Storek J; Voltarelli JC; Burns WH
Lancet Neurol; 2009 Mar; 8(3):244-53. PubMed ID: 19186105
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of undetermined significance related pyoderma gangrenosum successfully treated with autologous peripheral blood stem cell transplantation.
Chang CM; Hwang WL; Hsieh ZY; Wang RC; Teng CL
Ann Hematol; 2010 Aug; 89(8):823-4. PubMed ID: 20013121
[No Abstract] [Full Text] [Related]
15. High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
.
Lepori N; Cheungpasitporn W; Sethi S; Murray D; Kumar S; Leung N; Giridhar KV; Fervenza FC
Clin Nephrol; 2018 Apr; 89(4):291-299. PubMed ID: 29249234
[TBL] [Abstract][Full Text] [Related]
16. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
17. Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
Wannesson L; Zucca E
Nat Clin Pract Oncol; 2008 Aug; 5(8):442-3. PubMed ID: 18607392
[No Abstract] [Full Text] [Related]
18. Renal transplant in plasma cell dyscrasias with lenalidomide treatment after autologous stem cell transplantation.
Sánchez Quintana A; Rull PR; Atienza JB; McDonnell CN
Nephrology (Carlton); 2013 Sep; 18(9):641-3. PubMed ID: 23980813
[TBL] [Abstract][Full Text] [Related]
19. Management of newly diagnosed myeloma.
Rajkumar SV; Palumbo A
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1141-56, ix-x. PubMed ID: 17996592
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
